Harmony Biosciences Holdings, Inc. (HRMY) Revenue & EPS Growth Rates 2026 | EvidInvest

Growth Analysis - HRMY

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth21.51%

5Y CAGR40.30%

10Y CAGRN/A

Net Income

1Y Growth9.07%

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y Growth7.81%

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y Growth9.75%

5Y CAGR68.35%

10Y CAGRN/A

EBITDA

1Y Growth9.27%

5Y CAGR178.84%

10Y CAGRN/A

Capex

1Y Growth-73.11%

5Y CAGR-31.14%

10Y CAGRN/A

Equity

1Y Growth32.02%

5Y CAGR55.03%

10Y CAGRN/A

Cash Flow

1Y Growth58.40%

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	21.5%	22.2%	25.6%	40.3%	N/A	N/A	N/A	N/A
FY 2024 Dec 31, 2024	22.8%	27.8%	32.8%	160.2%	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	32.9%	38.0%	53.9%	N/A	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	43.4%	65.6%	318.0%	N/A	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	91.2%	613.8%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2020 Dec 31, 2020	2564.6%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2019 Dec 31, 2019	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2018 Dec 31, 2018	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - HRMY

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Harmony Biosciences Holdings, Inc.

Compare with peers

Explore

Growth Analysis - HRMY

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Harmony Biosciences Holdings, Inc.

Compare with peers

Explore